C. Féray

发表

External validation of the Donor Risk Index and the Eurotransplant Donor Risk Index on the French liver transplantation registry

C. Jacquelinet, R. Écochard, F. Roudot-thoraval, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Viruses and miRNAs: More Friends than Foes

Silvia Bottini, Jean-Michel Pawlotsky, J. Pawlotsky, 2017, Front. Microbiol..

Liver Transplantation with “Hors Tour” Allocated Versus Standard MELD Allocated Grafts: Single-Center Audit and Impact on the Liver Pool in France

A. Winter, C. Féray, D. Azoulay, 2019, World Journal of Surgery.

Hepatitis viruses and liver transplantation

D. Samuel, H. Bismuth, C. Féray, 1997, Journal of gastroenterology and hepatology.

When the Patient Is Sicker Than His Liver.

G. Dhonneur, C. Féray, D. Azoulay, 2015, Annals of surgery.

Surgical Technique of Procurement and Liver Transplant

C. Féray, N. de’Angelis, A. Laurent, 2015 .

Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

T. Asselah, P. Marcellin, P. Bedossa, 2008, Gastroenterology.

Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

J. Albrecht, D. Samuel, H. Bismuth, 2003, Gastroenterology.

Genome-Wide Analysis of Host mRNA Translation during Hepatitis C Virus Infection

Céline Hernandez, R. Houlgatte, C. Féray, 2013, Journal of Virology.

CLINICAL-LIVER, PANCREAS, AND BILIARY TRACT Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C

T. Asselah, P. Marcellin, P. Bedossa, 2008 .

[Evaluation of results of liver transplantation: experience based on a series of 1052 transplantations].

O. Farges, D. Samuel, H. Bismuth, 1995, Presse medicale.

Clinical and therapeutic implications of hepatitis C virus compartmentalization.

D. Samuel, C. Féray, Guillaume Fallot, 2006, Gastroenterology.

Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study

J. Lefaucheur, S. Ayache, C. Féray, 2017, Journal of Neurology.

HBV DNA persistence 10 years after liver transplantation despite successful anti‐HBS passive immunoprophylaxis

D. Samuel, H. Bismuth, C. Féray, 2003, Hepatology.

Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes

F. Penin, Y. Richard, C. Féray, 2004, Hepatology.

A systematic review of auxiliary liver transplantation of small-for-size grafts in patients with chronic liver disease

D. Samuel, C. Féray, E. Vibert, 2022, JHEP reports : innovation in hepatology.

Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors

D. Samuel, J. Emile, C. Féray, 2002, Gut.

Novel Classification of Nonmalignant Portal Vein Thrombosis: A guide to Surgical Decision Making during Liver Transplantation.

C. Féray, D. Azoulay, E. Lahat, 2019, Journal of hepatology.

18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma: A prospective observational study.

C. Féray, E. Itti, D. Azoulay, 2018, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Orthotopic liver transplantation for alcoholic cirrhosis: a long time follow up

D. Samuel, H. Bismuth, C. Féray, 2001 .

Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation.

V. Paradis, D. Samuel, H. Bismuth, 1995, Gastroenterology.

An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection

V. Paradis, D. Samuel, H. Bismuth, 1995, Hepatology.

The course of hepatitis C virus infection after liver transplantation

V. Paradis, D. Samuel, H. Bismuth, 1994, Hepatology.

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

V. de Lédinghen, P. Marcellin, F. Carrat, 2013, Journal of hepatology.

Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study.

D. Thabut, D. Samuel, A. Duhamel, 2022, The lancet. Gastroenterology & hepatology.

The course of hepatitis C virus infection after liver transplantation

V. Paradis, D. Samuel, H. Bismuth, 1994, Hepatology.

Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients.

V. Paradis, D. Samuel, B. Debuire, 1998, Kidney international.

Heterotopic liver retransplantation for impossible former graft explantation

C. Féray, D. Azoulay, E. Lahat, 2017, Hepatology.

[Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience].

D. Samuel, H. Bismuth, C. Féray, 2001, Gastroentérologie Clinique et Biologique.

Recurrence of hepatitis C virus infection after liver transplantation.

D. Samuel, C. Féray, 1999, Journal of hepatology.

Long‐term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation

D. Samuel, H. Bismuth, C. Féray, 1997, Hepatology.

Long‐term outcome in liver transplantation candidates with portopulmonary hypertension

M. Humbert, D. Samuel, F. Durand, 2017, Hepatology.

The anhepatic phase of liver transplantation as a model for measuring the extra-hepatic replication of hepatitis C virus.

C. Féray, G. Di Liberto, 2005, Journal of hepatology.

A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C.

C. Bain, J. Limacher, C. Féray, 2011, Gastroenterology.

Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection

D. Samuel, C. Bréchot, C. Féray, 2007, Hepatology.

Invasive pulmonary aspergillosis in cirrhotic patients: analysis of a 10-year clinical experience

C. Féray, F. Botterel, E. Lévesque, 2019, Annals of Intensive Care.

Re 'Liver transplantation for sickle cell disease: a systematic' Feli et al.

C. Féray, F. Galactéros, P. Bartolucci, 2021, HPB : the official journal of the International Hepato Pancreato Biliary Association.

The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation.

S. Metral, C. Lacroix, D. Samuel, 2000, Brain : a journal of neurology.

Hepatitis C Virus Regulates its Replication by Maturing miR-122 Through Akt-Dependent Phosphorylation of KSRP

J. Pawlotsky, C. Féray, A. Rosenberg, 2019, bioRxiv.

Retreatment with sofosbuvir and simeprevir of patients with hepatitis C virus genotype 1 or 4 who previously failed a daclatasvir‐containing regimen

J. Pawlotsky, F. Roudot-thoraval, A. Mallat, 2016, Hepatology.

Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant

M. Buendia, J. Calderaro, D. Samuel, 2018, Hepatology.

Reinfection of liver graft by hepatitis C virus after liver transplantation.

D. Samuel, H. Bismuth, C. Bréchot, 1992, The Journal of clinical investigation.

Indocyanine green fluorescence patterns of hepatocellular carcinoma correlate with pathological and molecular features.

D. Samuel, C. Féray, E. Vibert, 2022, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Molecular and clinical characteristics of the hepatitis C virus genotype ‘2c’ found in Italians in Italy and France☆

C. Bréchot, C. Féray, S. Mishiro, 1995 .

Liver transplantation in patients with end‐stage liver disease requiring intensive care unit admission and intubation

G. Dhonneur, C. Féray, D. Azoulay, 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Évaluation du devenir post-transplantation hépatique des patients cirrhotiques selon leur grade ACLF

C. Féray, D. Azoulay, J. Merle, 2014 .

Genotype lb and severity of posttransplant recurrence of hepatitis C infection—unconvictable felon or wrongly accused?

G. Alexander, J. Gugenheim, C. Féray, 2000 .

The presence of epithelioid granulomas in hepatitis C virus-related cirrhosis.

J. Emile, C. Féray, M. Sebagh, 1993, Human pathology.

Hepatitis B virus replicating in hepatocellular carcinoma encodes HBx variants with preserved ability to antagonize restriction by Smc5/6.

M. Buendia, C. Féray, Guillaume Fallot, 2019, Antiviral research.

An Oxygenated and Transportable Machine Perfusion System Fully Rescues Liver Grafts Exposed to Lethal Ischemic Damage in a Pig Model of DCD Liver Transplantation

J. Calderaro, C. Féray, A. Corlu, 2017, Transplantation.

Journal Pre-proof Early Deregulation Of Cholangiocyte NR0B2 During Primary Sclerosing Cholangitis

D. Samuel, C. Féray, C. Desterke, 2022 .

Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes

P. Marcellin, C. Féray, S. Vagner, 2010, Gut.

Long‐term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis

D. Mathieu, D. Samuel, H. Bismuth, 1995, Hepatology.

Is HCV infection a neurologic disorder?

C. Féray, 2012, Gastroenterology.

Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection.

D. Samuel, C. Bréchot, C. Féray, 1997, Journal of hepatology.

Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. The liver transplantation model.

D. Samuel, H. Bismuth, C. Bréchot, 1990, Transplantation.

De novo and apparent de novo hepatitis B virus infection after liver transplantation.

D. Samuel, H. Bismuth, C. Féray, 1997, Journal of hepatology.

HCV type II has a more pathogenic course after liver transplantation

C. Féray, 1993 .

Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France.

D. Samuel, H. Bismuth, C. Bréchot, 1993, Journal of hepatology.

Risk of liver retransplantation for viral hepatitis

D. Samuel, H. Bismuth, C. Féray, 1997 .

Nodular Regenerative Hyperplasia Is Not a Rare Condition After Liver Transplantation: Incidence, Predictive Factors, and Impact on Survival

D. Samuel, C. Féray, E. Vibert, 2022, Transplantation.

Amplification of hepatitis delta virus RNA sequences by polymerase chain reaction: a tool for viral detection and cloning.

C. Bréchot, C. Féray, P. Tiollais, 1990, Molecular and cellular probes.

Hepatic Iron Overload following Liver Transplantation from a C282Y/H63D Compound Heterozygous Donor

J. Calderaro, E. Pras, O. Pappo, 2018, Case reports in hepatology.

Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection

D. Trégouët, M. Abdel-hamid, A. Fontanet, 2008, Gut.

Nonrandom Distribution of Hepatitis C Virus Quasispecies in Plasma and Peripheral Blood Mononuclear Cell Subsets

F. Penin, D. Samuel, H. Bismuth, 1999, Journal of Virology.

A Novel Method to Identify Routes of Hepatitis C Virus Transmission

Mohamed Abdel-Hamid, Bruno Falissard, M. Abdel-hamid, 2014, PloS one.

Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen

D. Samuel, C. Féray, B. Roche, 2001, Journal of medical virology.

Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration.

D. Samuel, H. Bismuth, C. Féray, 1995, Journal of hepatology.

Disseminated Toxoplasmosis, Resulting from Infection of Allograft, after Orthotopic Liver Transplantation: Usefulness of Quantitative PCR

D. Samuel, C. Féray, F. Saliba, 2002, Journal of Clinical Microbiology.

Male cell microchimerism in normal and diseased female livers from fetal life to adulthood

J. Buard, D. Samuel, C. Féray, 2005, Hepatology.

Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation.

D. Samuel, H. Bismuth, P. Majno, 1999, Journal of hepatology.

Retransplantation of the liver for recurrent hepatitis B virus infection: the Paul Brousse experience.

D. Samuel, H. Bismuth, P. Majno, 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence

D. Samuel, H. Bismuth, E. Ballot, 2003, Gut.

2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus‐related infection before and after liver transplantation

M. Buti, P. Cortesi, F. Zoulim, 2021, Alimentary pharmacology & therapeutics.

Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis.

G. Reyes, D. Samuel, H. Bismuth, 1993, Gastroenterology.

Recombination of hepatitis B virus DNA in patients with HIV

D. Samuel, C. Féray, Guillaume Fallot, 2011, Gut.

Could post‐liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?

D. Samuel, H. Bismuth, E. Ballot, 2005, Clinical transplantation.

Viral and clinical factors associated with the fulminant course of hepatitis A infection

D. Samuel, H. Bismuth, C. Féray, 2003, Hepatology.

Incidence of Hepatitis C in Patients Receiving Different Preparations of Hepatitis B Immunoglobulins after Liver Transplantation

D. Samuel, H. Bismuth, C. Féray, 1998, Annals of Internal Medicine.

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.

G. Alexander, D. Samuel, H. Bismuth, 1999, Gastroenterology.

Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease.

O. Farges, D. Samuel, H. Bismuth, 1999, Journal of hepatology.

Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation.

Philippe Ichai, Faouzi Saliba, Didier Samuel, 2002, Transplantation.

INFLUENCE OF LIVER HEPATITIS C VIRUS RNA AND HEPATITIS C VIRUS GENOTYPE ON FAS-MEDIATED APOPTOSIS AFTER LIVER TRANSPLANTATION FOR HEPATITIS C

V. Paradis, D. Samuel, H. Bismuth, 2000, Transplantation.

Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus

D. Samuel, H. Bismuth, C. Féray, 2007, Hepatology.

Systematic review: anti‐viral therapy of recurrent hepatitis C after liver transplantation

C. Féray, P. Guillouche, Pauline Guillouche, 2010, Alimentary pharmacology & therapeutics.

Quality of life 10 years after liver transplantation: The impact of graft histology

D. Samuel, C. Féray, F. Saliba, 2016, World journal of transplantation.

Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient

D. Samuel, H. Bismuth, C. Féray, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Intense isolated expression with preS1 (large protein) antibodies in the liver graft associated with severe acute hepatitis B virus reactivation.

D. Samuel, J. Emile, C. Féray, 2001, Journal of hepatology.

Genotyping and resistance profile of hepatitis C (HCV) genotypes 1-6 by sequencing the NS3 protease region using a single optimized sensitive method.

C. Féray, B. Besse, N. Bourgeois, 2012, Journal of virological methods.

Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery.

A. Luciani, J. Calderaro, C. Féray, 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Liver transplantation in patients with sickle cell disease: possible but challenging—a cohort study

C. Féray, C. Duvoux, F. Galactéros, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

Assessment of the results of liver transplantation and definition of criteria for the evaluation of transplant centers.

O. Farges, D. Samuel, H. Bismuth, 1997, Transplantation proceedings.

Transplantation hépatique de l'adulte à partir de donneur vivant

D. Samuel, H. Bismuth, C. Féray, 2008 .

Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.

D. Samuel, J. Dumortier, F. Durand, 2016, World journal of gastroenterology.

Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients

D. Lavillette, F. Cosset, C. Féray, 2015, Journal of Virology.

Genetic Clustering of Hepatitis C Virus Strains and Severity of Recurrent Hepatitis after Liver Transplantation

F. Penin, B. Falissard, C. Féray, 2001, Journal of Virology.

Will transplantation of an hepatitis C-infected graft improve the outcome of liver transplantation in HCV patients?

D. Samuel, C. Féray, D. Shouval, 1999, Gastroenterology.

Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseases.

P. Marcellin, C. Bréchot, S. Pol, 2000, Journal of hepatology.

Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study.

M. Van Ranst, J. Izopet, D. Roulot, 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Post–Liver Transplantation Sinusoidal Obstruction Syndrome With Refractory Ascites Induced by Mycophenolate Mofetil

D. Samuel, H. Bismuth, C. Féray, 2020, Hepatology.

Compartmentalization of Hepatitis C Virus Genotypes between Plasma and Peripheral Blood Mononuclear Cells

D. Samuel, C. Féray, A. Roque-Afonso, 2005, Journal of Virology.

Towards predicting the therapeutic response in patients with hepatitis C

C. Féray, 2009, Alimentary pharmacology & therapeutics.

[Current management of hepatocellular carcinoma].

C. Féray, I. Ruiz, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study.

M. Ziol, S. Imbeaud, J. Zucman‐Rossi, 2021, The Lancet. Oncology.

Donor HLA Class 1 Evolutionary Divergence Is a Major Predictor of Liver Allograft Rejection

D. Samuel, C. Féray, F. Saliba, 2020, Annals of Internal Medicine.

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas

T. Molina, F. Berger, F. Carrat, 2016, PloS one.

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B‐cell non‐Hodgkin lymphomas, ANRS HC‐13 lympho‐C study

T. Molina, F. Berger, F. Carrat, 2015, American journal of hematology.

Impact of time to surgery in the outcome of patients with liver resection for BCLC 0-A stage hepatocellular carcinoma.

A. Luciani, J. Calderaro, C. Féray, 2017, Journal of hepatology.

Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent‐to‐treat analysis

K. Hasegawa, C. Féray, N. Kokudo, 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).

A. Samri, B. Autran, D. Samuel, 2009, Journal of hepatology.

Acute kidney injury following hepatectomy for hepatocellular carcinoma: incidence, risk factors and prognostic value.

G. Dhonneur, C. Féray, E. Audureau, 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Should we screen blood products for hepatitis E virus RNA ?

J. Pawlotsky, D. Dhumeaux, D. Samuel, 2014, The Lancet.

Candida vascular complication in a liver transplant recipient due to yeast contamination of preservation solution

R. Amathieu, G. Dhonneur, C. Féray, 2014, Transplant infectious disease : an official journal of the Transplantation Society.

Risk factors for hepatocellular carcinoma in Caucasian patients with non‐viral cirrhosis: the importance of prior obesity

D. Samuel, P. Nahon, L. Planche, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation

A. Luciani, J. Calderaro, C. Féray, 2016, Progress in transplantation.

Primary leiomyosarcoma of the liver: Two new cases and a systematic review

J. Calderaro, C. Féray, L. Baranes, 2020, Annals of hepato-biliary-pancreatic surgery.

Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study

A. Luciani, J. Belghiti, C. Féray, 2017, Annals of surgery.

Should we use liver grafts repeatedly refused by other transplant teams?

C. Jacquelinet, J. Daurès, P. Landais, 2020, JHEP reports : innovation in hepatology.

A Donor Quality Index for liver transplantation: development, internal and external validation

J. Daurès, P. Landais, A. Winter, 2018, Scientific Reports.

Donor age influences 10-year liver graft histology independently of hepatitis C virus infection.

D. Samuel, H. Bismuth, C. Féray, 2004, Journal of hepatology.

All liver recipients benefit from the protocol 10‐year liver biopsies

D. Samuel, H. Bismuth, B. Falissard, 2003, Hepatology.

Safety of laparoscopic hepatectomy in patients with hepatocellular carcinoma and portal hypertension: interim analysis of an open prospective study

C. Féray, A. Doussot, F. Hemery, 2018, Surgical Endoscopy.

Hepatic Arteriovenous Malformation: The Search for a PTEN Mutation!

D. Samuel, M. Eyries, C. Féray, 2021, Hepatology.

NR0B2 regulation during Primary Sclerosing Cholangitis defines a metabolic and pre-malignant reprogramming of Cholangiocyte

C. Féray, C. Desterke, 2021, bioRxiv.

Long‐term results of combined liver‐kidney transplantation for primary hyperoxaluria type 1: The French Experience

D. Samuel, K. Boudjema, L. Rostaing, 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention‐to‐treat analysis

A. Luciani, J. Calderaro, C. Féray, 2018, Hepatology.

[Pneumocystis carinii and cytomegalovirus pneumonia after corticosteroid therapy in acute severe alcoholic hepatitis: 2 case reports].

D. Samuel, H. Bismuth, C. Féray, 2002, Gastroenterologie clinique et biologique.

Complications after Hepatectomy for Hepatocellular Carcinoma Independently Shorten Survival: A Western, Single-Center Audit

C. Féray, A. Doussot, D. Azoulay, 2017, Annals of Surgical Oncology.

Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients.

D. Samuel, H. Bismuth, C. Féray, 2005, Journal of hepatology.

Liver transplantation in elderly patients: a systematic review and first meta-analysis.

C. Féray, K. Gurusamy, D. Azoulay, 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

The utility of ECMO, not just after but also during Liver Transplantation.

C. Féray, D. Azoulay, C. Salloum, 2019, Transplantation.

Defining Surgical Difficulty of Liver Transplantation

C. Féray, E. Ramos, L. Lladó, 2021, Annals of surgery.

Impact of acute‐on‐chronic liver failure on 90‐day mortality following a first liver transplantation

J. Daurès, P. Landais, A. Winter, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Paul Brousse Liver Transplantation: the first 1,500 cases.

D. Samuel, H. Bismuth, C. Féray, 2000, Clinical transplants.

[Clinical and virological aspects of hepatitis C virus infection in liver transplantation].

D. Samuel, H. Bismuth, C. Féray, 1995, Gastroentérologie Clinique et Biologique.

595 Evidence for eradication of HCV, assessed with transcription mediated amplification (TMA), in chronic hepatitis C patients with sustained virological response to therapy

P. Marcellin, C. Féray, M. Nicolas-Chanoine, 2006 .

Patient with decompensated hepatitis C virus–related cirrhosis delisted for liver transplantation after successful sofosbuvir‐based treatment

J. Pawlotsky, C. Féray, C. Hézode, 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Low cross-neutralization of hepatitis C correlates with liver disease in immunocompromized patients

D. Lavillette, F. Cosset, D. Samuel, 2015, AIDS.

Sleeve Gastrectomy After Liver Transplantation: Feasibility and Outcomes

C. Féray, D. Azoulay, C. Salloum, 2017, Obesity Surgery.

Liver transplantation as a model to better understand the cell entry of hepatitis C virus.

C. Féray, 2011, Journal of hepatology.

Is PD-1 blockade a potential therapy for HBV?

C. Féray, F. López-Labrador, 2019, JHEP reports.

Early liver transplantation for severe alcoholic hepatitis not responding to medical treatment: results of the French-Belgian prospective study QuickTrans

D. Thabut, D. Samuel, A. Duhamel, 2020 .

Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.

C. Féray, 2004, Journal of hepatology.

Tumors located in the central column of the liver are associated with increased surgical difficulty and postoperative complications following open liver resection for colorectal metastases.

C. Féray, F. Saliba, E. Vibert, 2022, HPB : the official journal of the International Hepato Pancreato Biliary Association.

TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial

A. Luciani, C. Féray, L. Mineur, 2023, JHEP reports : innovation in hepatology.

A randomized trial comparing TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma

A. Luciani, C. Féray, L. Mineur, 2023, JHEP Reports.

Long-Term Results of Transplantation for Hepatocellular Carcinoma With or Without Cirrhosis: 15 Years’-Experience at Paul Brousse Hospital

D. Samuel, H. Bismuth, C. Féray, 2002 .

Short-term outcomes following hepatectomy for hepatocellular carcinoma within and beyond the BCLC guidelines: A prospective study.

A. Luciani, C. Féray, D. Azoulay, 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Liver transplantation for viral hepatitis: the experience of the hepatobiliary center at Hospital Paul Brousse.

D. Samuel, H. Bismuth, C. Féray, 1994, Clinical transplants.

Adefovir therapy for HBV infection after liver transplantation (LT)

D. Samuel, H. Bismuth, C. Féray, 2002 .

The impact of advanced patient age in liver transplantation: a European Liver Transplant Registry propensity-score matching study.

K. Zieniewicz, K. Boudjema, C. Fondevila, 2021, HPB : the official journal of the International Hepato Pancreato Biliary Association.

13 Liver transplantation of HIV-HCV and HIV-HBV coinfected patients: A large experience in a single centre

D. Samuel, H. Bismuth, C. Féray, 2006 .

124 HCV viral recurrence and liver mitochondrial damage after liver transplantation (LT) in HIV-HCV coinfected patients

D. Samuel, C. Féray, F. Saliba, 2004 .

Long‐term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis

D. Mathieu, D. Samuel, H. Bismuth, 1995, Hepatology.

Clinical Outcomes of Right-Lobe Split-Liver versus Orthotopic Liver Transplants from Donors More than 70 Years Old

C. Féray, N. de’Angelis, A. Laurent, 2015, Progress in transplantation.

Matching Graft Quality to Recipient’s Disease Severity Based on the Survival Benefit in Liver Transplantation

J. Daurès, P. Landais, A. Winter, 2020, Scientific Reports.

Author Correction: A Donor Quality Index for liver transplantation: development, internal and external validation

J. Daurès, P. Landais, A. Winter, 2018, Scientific Reports.

P.173 Clinical and therapeutic implications of HCV compartmentalization

G. D. Liberto, D. Samuel, C. Féray, 2006 .

Evidence for Alloimmune Sinusoidal Injury in De Novo Nodular Regenerative Hyperplasia After Liver Transplantation

D. Samuel, C. Féray, F. Saliba, 2023, Transplant international : official journal of the European Society for Organ Transplantation.

A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C.

C. Bain, J. Limacher, C. Féray, 2011, Gastroenterology.

Impact of time to surgery in the outcome of patients with liver resection for BCLC 0-A stage hepatocellular carcinoma.

A. Luciani, J. Calderaro, C. Féray, 2017, Journal of hepatology.

A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence

D. Samuel, H. Bismuth, E. Ballot, 2003, Gut.

Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes

P. Marcellin, C. Féray, S. Vagner, 2010, Gut.

Impact on Oncological Outcomes and Intent-to-Treat Survival of Resection Margin for Transplantable Hepatocellular Carcinoma in All-Comers and in Patients with Cirrhosis: A Multicenter Study

J. Figueras, C. Féray, E. Ramos, 2020, World Journal of Surgery.

Short-term outcomes following hepatectomy for hepatocellular carcinoma within and beyond the BCLC guidelines: A prospective study.

A. Luciani, C. Féray, D. Azoulay, 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Recombination of hepatitis B virus DNA in patients with HIV

D. Samuel, C. Féray, Guillaume Fallot, 2011, Gut.

Rescue Liver Transplantation for Posthepatectomy Liver Failure: A Systematic Review and Survey of an International Experience

C. Féray, F. Saliba, E. Vibert, 2023, Transplantation.

Identification of liver transplant biopsy phenotypes associated with distinct liver biological markers and allograft survival.

A. Loupy, C. Féray, M. Raynaud, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Liver transplant selection criteria and outcomes in critically ill patients with ACLF

C. Féray, F. Saliba, A. Coilly, 2023, JHEP reports : innovation in hepatology.